San Francisco-based
Lemonaid Health, which provides prescription delivery of such sensitive prescriptions as birth control bills, urinary tract infection (UTI), acne, hair loss, and other conditions, has raised $12M in a Series A funding, the company announced today. The funding was led by Novartis Venture Fund and Hikma Ventures and also included Quest Diagnostics, Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures, and 415 Ventures. The new funding comes on top of an earlier, $15M funding raised by the company in December of 2015.
posted on Monday, May 22, 2017
Related companies:
Lemonaid Health
Related stories:
> Hinge Health Picks Up $26M
> DynoSense Picks Up $9.4M For Remote Health Monitoring Sensor
> Drchrono Picks Up $12M
> Limelight Health Finds $3M
> Jiff Picks Up $17.7M More
silicontap.com Home